Phaos Technology Holdings (Cayman) (POAS) Cash & Current Investments (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Cash & Current Investments came in at $42673.9 in Q4 2025, down 55.97% on a QoQ basis from $96918.3 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Cash & Current Investments (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Cash & Current Investments data on file, last reported at $42673.9 in Q4 2025.
- Quarterly Cash & Current Investments changed N/A year-over-year to $42673.9 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $42673.9 (changed N/A YoY) and the FY2025 annual result came in at $97007.0, down 94.35% from the prior year.
- Cash & Current Investments slipped to $42673.9 in Q4 2025, from $96918.3 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $1.7 million in Q2 2024 to a low of $42673.9 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 4.23 Mn | 4.19 Mn | - | 42,673.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 42,673.91 |
| Apr 30, 2025 | 96,918.26 |
| Apr 30, 2024 | 1.72 Mn |